(Q39374368)

11 September 2017

title

Ethnic differences in the distribution of CYP3A5 gene polymorphisms (English)

1 reference

11 September 2017

author

Florence Migot-Nabias

5

1 reference

11 September 2017

Quaranta S

1

1 reference

11 September 2017

Chevalier D

2

1 reference

11 September 2017

Allorge D

3

1 reference

11 September 2017

Lo-Guidice JM

4

1 reference

11 September 2017

Kenani A

6

1 reference

11 September 2017

Imbenotte M

7

1 reference

11 September 2017

Broly F

8

1 reference

11 September 2017

Lacarelle B

9

1 reference

11 September 2017

Lhermitte M

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

11 September 2017

1 reference

11 September 2017

volume

36

1 reference

11 September 2017

issue

12

1 reference

11 September 2017

page(s)

1191-1200

1 reference

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Sequence analysis, frequency and ethnic distribution of VNTR polymorphism in the 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

The role of individual human cytochromes P450 in drug metabolism and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Significance of the minor cytochrome P450 3A isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Pharmacogenomics, ethnicity, and susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

Genetic variability in CYP3A5 and its possible consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250600944300

10.1080/00498250600944300

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference